Filing Details

Accession Number:
0001385508-22-000058
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-16 16:05:15
Reporting Period:
2022-05-13
Accepted Time:
2022-05-16 16:05:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385508 Opiant Pharmaceuticals Inc. OPNT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1363558 A Craig Collard C/O Opiant Pharmaceuticals, Inc.
233 Wilshire Blvd., Suite 400
Santa Monica CA 90401
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-13 3,689 $10.49 20,972 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $10.47 to $10.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.